Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid’ launch

Thread starter U.S. News
Start date Jan 16, 2026

U.S. News

Guest

Jan 16, 2026

The early data is a boost to the Danish drugmaker's hopes of winning back more market share from Eli Lilly this year in the obesity drug space.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid’ launch

Prefix: N/A

Forum: USA News

Start date: Jan 16, 2026

Last reply date: Jan 16, 2026

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Jan 16, 2026

Replies: 0

Views: 10

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search